ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-30698

Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D).

Published Apr 15, 2025 · catalog updated Nov 3, 2025 · Oracle Corporation Oracle Java SE

Check if you run it

No confirmed exploitation is on record for CVE-2025-30698. EPSS is 0.63%. Act only if a listed version of Oracle Corporation Oracle Java SE is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.6
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.63%
Remediation
Advisory link
Affected products
vendor Oracle Corporation Oracle Java SE 21.0.6

Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u441, 8u441-perf, 11.0.26, 17.0.14, 21.0.6, 24; Oracle GraalVM for JDK: 17.0.14, 21.0.6, 24; Oracle GraalVM Enterprise Edition: 20.3.17 and 21.3.13. Difficult to exploit vulnerability allows unauthenticated attacker with network access via multiple protocols to compromise Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition. Successful attacks of this vulnerability can result in u

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Oracle Corporation Oracle Java SE 21.0.621.0.6

How to fix CVE-2025-30698

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-30698. EPSS is 0.63%. Act only if a listed version of Oracle Corporation Oracle Java SE is installed.

Which versions are affected?

Compare what you have installed with Oracle Corporation Oracle Java SE 21.0.6 21.0.6. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.63%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Apr 15, 2025 · EUVD

    Detected

    Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u441, 8u441-perf, 11.0.26, 17.0.14, 21.0.6, 24; Oracle GraalVM for JDK: 17.0.14, 21.0.6, 24; Oracle GraalVM Enterprise Edition: 20.3.17 and 21.3.13. Difficult to exploit vulnerability allows unauthenticat

  2. Nov 3, 2025 · EUVD

    Updated

    Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u441, 8u441-perf, 11.0.26, 17.0.14, 21.0.6, 24; Oracle GraalVM for JDK: 17.0.14, 21.0.6, 24; Oracle GraalVM Enterprise Edition: 20.3.17 and 21.3.13. Difficult to exploit vulnerability allows unauthenticat

Sources

  • CVE.orgVulnerability recordCVE-2025-30698

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-30698

    30-day exploitation probability 0.6%

    first.org
  • EUVDVulnerability recordEUVD-2025-11051

    Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u441, 8u441-perf, 11.0.26, 17.0.14, 21.0.6, 24; Oracle GraalVM for JDK: 17.0.14, 21.

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.